Psychiatr. praxi 2018; 19(3): 96-100 | DOI: 10.36290/psy.2018.020

New psychoactive substances in Europe and Czech Republic

Mgr. Kateřina Grohmannová1, 2, 3, doc. MUDr. Viktor Mravčík, Ph.D.1, 4, 5
1 Národní ústav duševního zdraví, Klecany
2 Národní monitorovací středisko pro drogy a závislosti, Praha
3 Institut pro kriminologii a sociální prevenci, Praha
4 Národní monitorovací středisko pro drogy a závislosti, Praha
5 Klinika adiktologie Všeobecné fakultní nemocnice a 1. lékařské fakulty Univerzity Karlovy v Praze

New psychoactive substances (NPS) have appeared on the European drug scene for the last 15 years. In the Czech Republic, theirprevalence is noticeable since 2010. NPS represent various chemical groups with various effects imitating the effects of illicitdrugs. They are supplied as legal highs, research chemicals, food supplements or medicinal products. The supply of NPS on thedrug market is changing quite rapidly. Situation on availability of NPS is being monitored by the early warning system. In 2016, 44NPS were newly reported in the Czech Republic, most commonly synthetic cathinones. Serious health consequences are mostlyassociated with synthetic cathinones, synthetic cannabinoids and new synthetic opioids. Early identification of NPS allows forcausal treatment significantly reducing the risk of severe health consequences.

Keywords: new psychoactive substances, legal highs, acute intoxication, early warning system

Published: October 15, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Grohmannová K, Mravčík V. New psychoactive substances in Europe and Czech Republic. Psychiatr. praxi. 2018;19(3):96-100. doi: 10.36290/psy.2018.020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mravčík V, et al. Výroční zpráva o stavu ve věcech drog v České republice v roce 2011. 2012, Praha: Úřad vlády ČR.
    2. Mravčík V, et al. Nové psychoaktivní látky a jejich výskyt v ČR. Čas. Lék. čes., 2015. 154 (5): p. 216-221.
    3. Mravčík V, et al. Nové psychoaktivní látky v České republice: výskyt rizika a související opatření. 2015, Praha: Klinika adiktologie 1. LF UK v Praze a VFN v Praze.
    4. Mravčík V, et al. Narcotic and Psychotropic Substances Are... - a Proposal for a Legal Definition of Illicit Drugs in the Czech Republic. Adiktologie, 2016. 16(2): p. 156-164. Notes: V češtině přetištěno jako Omamné a psychotropní látky jsou když... - návrh legislativní definice omamných a psychotropních látek v ČR, Trestněprávní revue 5/2016, s. 111-116.
    5. EMCDDA, New psychoactive substances in Europe. An update from the EU Early Warning System, March 2015., ed. EMCDDA. 2015, Luxembourg: Publications Office of the European Union.
    6. Mravčík V, et al. eds. Nové psychoaktivní látky v České republice: výskyt, rizika a související opatrení. 1st ed. 2015, Klinika adiktologie 1. LF UK v Praze a VFN v Praze.
    7. EMCDDA, European Drug Report 2017. Trends and development. 2017.
    8. EMCDDA and Europol, EMCDDA-Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA. 2017, EMCDDA: Luxembourg.
    9. European Monitoring Centre for Drugs and Drug Addiction and Europol, Drugs and the darknet: Perspectives for enforcement, research and policy, in EMCDDA-Europol Joint publications. 2017: Luxembourg.
    10. Murphy CM, et al, "Bath salts" and "plant food" products: the experience of one regional US poison center. J Med Toxicol, 2013. 9(1): p. 42-48. Go to original source... Go to PubMed...
    11. Ross EA, Watson M, and Goldberger B "Bath salts" intoxication. N Engl J Med, 2011. 365(10): p. 967-968. Go to original source...
    12. Spiller HA, et al. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila), 2011. 49(6): p. 499-505. Go to original source... Go to PubMed...
    13. Wood DM, et al. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila), 2010. 48(9): p. 924-927. Go to original source... Go to PubMed...
    14. NIDA, Synthetic Cannabinoids. 2015.
    15. EMCDDA, PERSPECTIVES ON DRUGS. Synthetic cannabinoids in Europe. 2017, EMCDDA: Lisbon.
    16. Grolmusová L, Mravčík V. Nové syntetické drogy: aktuální situace. Zaostřeno na drogy, 2012. 10(5): p. 1-11.
    17. Mravčík V, et al. Výroční zpráva o stavu ve věcech drog v České republice v roce 2016. 2017, Praha: Úřad vlády České republiky.
    18. Klíma J. Užívání omamných látek a vnímání jejich rizikovosti u návštěvníků hudebních akcí s elektronickou taneční hudbou, in Filozofická fakulta, Psychologický ústav. 2016, Masarykova univerzita: Brno. p. 108.
    19. Zazula R, Rakovcová H. Současné trendy v léčbě intoxikací. Interní medicína pro praxi, 2004(9): p. 454-458.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.